Journal of Targeted Oncology Research

Dr Zahra Mozooni

DVM

  • Department: Immunology Research Center
  • University: Iran University of Medical Sciences
  • Country: Iran

Dr. Zahra Mozooni is a Doctor of Veterinary Medicine (DVM) and a dedicated cancer researcher from Iran, specializing in gastrointestinal and urogenital oncology. She has over five years of research experience focused on molecular oncology, tumor immunology, and gene-based diagnostic development. Dr. Mozooni has collaborated with several prestigious Iranian institutions, including the Immunology Research Center at Iran University of Medical Sciences and the Genetics Research Center at Shahid Beheshti University of Medical Sciences. Her research has primarily centered on developing rapid stool- and urine-based diagnostic tests for colorectal and bladder cancers, as well as exploring genetic vector-based tumor suppressor gene delivery. She has authored 10 peer-reviewed publications, accumulating over 40 citations, and has presented her findings at international scientific conferences, including an invited presentation at a conference in Canada. In addition to her research achievements, Dr. Mozooni serves as a peer reviewer for leading international journals such as BMC Cancer, Discover Oncology, and the World Journal of Surgical Oncology.

1. Research Collaborations

  • Immunology Research Center, Iran University of Medical Sciences

  • Genetics Research Center, Shahid Beheshti University of Medical Sciences

  • Conducted advanced research in molecular oncology, focusing on gene expression, cytokine profiling, and immunological pathways in colorectal cancer.

  • Collaborated on interdisciplinary studies integrating molecular biology, immunogenetics, and cancer diagnostics.

2. Publications

  • Authored and co-authored 10 peer-reviewed scientific papers published in high-impact international journals such as ScienceDirect, Tandfonline, PMC, and Probiologists.

  • Research topics include interferon-gamma signaling, TNF receptors, MMP and TYK2 gene expression, and circular RNAs in colorectal cancer.

  • Publications have received over 40 citations, demonstrating the impact of her work in the field of molecular oncology.

3. Conference Presentations

  • International Conference on Immunology and Microbiology, Canada (2023) – Oral Presentation.

  • 16th International Congress of Allergy and Immunology, Iran University of Medical Sciences (2023) – Oral/Poster Presentation.

  • 13th, 14th, and 16th International Congresses on Laboratory and Clinical Medicine (2022–2024) – Poster Presentations on colorectal cancer research.

  • Symposium on Microbiome and Health (2021) – Poster Presentation.

  • 7th Annual Multidisciplinary Uro-oncology Congress (2025) – Poster Presentation on prostate cancer research.

4. Peer Review Activities

  • Peer Reviewer for international journals, including:

    • BMC Cancer

    • Discover Oncology

    • World Journal of Surgical Oncology

5. Professional Development and Training

  • Biostatistics and Data Analysis Workshop, Dr. Khalili Training Center – 40 hours

  • Cell Culture and Stem Cell Training – 4 hours

  • Gained expertise in RT-PCR, RNA extraction, cDNA synthesis, and data interpretation.

6. Research Goals

  • To advance early, non-invasive cancer diagnostics and gene-based therapeutic approaches.

  • To contribute to global oncology research through international collaboration and innovative translational studies.

  • Relationships between MMP-2, MMP-9, and ADAMDEC1 serum and tissue levels in patients with colorectal cancer
  • TNF-α, and TNFRs in gastrointestinal cancers
  • The Relationship Between Serum IgE Level and IL-4 and IL-13 Cytokines in Colorectal Cancer Patients
  • Clinicopathological characteristics of SMAD4 gene expressions in colorectal cancer patients
  • The Relationship Between Serum and Tissue Levels of IL-13 and TYK2 in Colorectal Cancer Patients
  • Investigation of GNB1 derivative circular RNAs hsa_circ_0009361 and hsa_circ_0009362 expressions in colorectal cancer patients: potential new diagnostic factors
  • Molecular Characteristics of TYK2 Gene Expressions in Patients with Colorectal Cancer
  • The Role of Interferon-gamma and Its Receptors in Gastrointestinal Cancers
  • The relationship between serum IgE level and IL-4 and IL-13 cytokines in colorectal cancer patients